CVS Health's (NYSE:CVS) Buy Rating Reiterated at Raymond James Financial

Cornelia Mascio
Dicembre 17, 2017

Clearbridge Investments Llc sold 1.57 million shares as the company's stock declined 4.23% while stock markets rallied. The institutional investor held 32,911 shares of the medical and nursing services company at the end of 2017Q2, valued at $2.65M, down from 39,281 at the end of the previous reported quarter. Stoneridge Investment Partners Llc who had been investing in Cvs Health Corporation for a number of months, seems to be less bullish one the $74.04B market cap company. Eqis Capital Management Inc. now owns 36,592 shares of the pharmacy operator's stock worth $2,872,000 after buying an additional 2,793 shares in the last quarter. About 14.33 million shares traded or 57.52% up from the average.

Thrivent Financial For Lutherans lessened its holdings in shares of CVS Health Corp (NYSE:CVS) by 30.1% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. It has underperformed by 41.10% the S&P500.

Ntv Asset Management Llc decreased its stake in Hershey Co (HSY) by 85.6% based on its latest 2017Q2 regulatory filing with the SEC. After $1.50 actual earnings per share reported by CVS Health Corporation for the previous quarter, Wall Street now forecasts 26.67% EPS growth. Cim Investment Mangement Inc who had been investing in Starbucks for a number of months, seems to be less bullish one the $82.94 billion market cap company. The stock decreased 0.32% or $0.04 during the last trading session, reaching $12.31. The stock was sold at an average price of $80.00, for a total transaction of $18,440,800.00. Lam Research Corporation (NASDAQ:LRCX) has risen 107.86% since December 16, 2016 and is uptrending.

Since August 16, 2017, it had 0 insider purchases, and 7 insider sales for $58.32 million activity. Another trade for 400 shares valued at $43,200 was sold by Buck Michele. Shares for $9.98M were sold by FEDERIGHI CRAIG on Monday, August 7.

Stoneridge Investment Partners Llc, which manages about $1.01 billion and $671.20 million US Long portfolio, upped its stake in Freeport (NYSE:FCX) by 66,223 shares to 355,542 shares, valued at $4.27M in 2017Q2, according to the filing.

Analysts await CVS Health Corporation (NYSE:CVS) to report earnings on February, 8. The company's quarterly revenue was up 3.5% compared to the same quarter past year. LRCX's profit will be $594.35 million for 12.69 P/E if the $3.67 EPS becomes a reality. Therefore 83% are positive. The Hershey Company had 52 analyst reports since August 5, 2015 according to SRatingsIntel. Wedbush maintained the shares of SBUX in report on Wednesday, September 28 with "Outperform" rating. HSBC downgraded Grifols, S.A. (NASDAQ:GRFS) on Wednesday, December 2 to "Hold" rating. Citigroup has "Neutral" rating and $87 target. The company now has an average rating of "Buy" and a consensus target price of $86.35. The firm earned "Outperform" rating on Wednesday, February 1 by RBC Capital Markets. The stock of Comcast Corporation (NASDAQ:CMCSA) has "Neutral" rating given on Tuesday, September 29 by Macquarie Research. The company was maintained on Monday, October 31 by Stifel Nicolaus. Banque Pictet Cie invested in 147,640 shares. 64 funds opened positions while 194 raised stakes. Penn Davis Mcfarland reported 201,008 shares. Citigroup Inc reported 178,406 shares. Biltmore Wealth Management Ltd Liability Corporation has 0.44% invested in CVS Health Corporation (NYSE:CVS). Toronto Dominion Bank lifted its position in shares of CVS Health by 18.6% during the second quarter. Busey Co reported 0.04% stake. Alliancebernstein Limited Partnership holds 10,950 shares. It specializes in point-of-sale, property management, inventory and procurement, workforce management, and mobile and wireless solutions that are created to streamline operations, enhance efficiency, increasing guest recruitment and wallet share, and enhance the overall guest experience. Moreover, Manchester Cap Mngmt Limited Liability Company has 0.05% invested in CVS Health Corporation (NYSE:CVS). 871 were accumulated by Next Gp. Alpine Woods Ltd Llc owns 392,222 shares or 0.82% of their USA portfolio. North Star Asset Management owns 115,035 shares for 1.69% of their portfolio. Horizon Kinetics Ltd Liability Company invested in 2,917 shares. It also reduced its holding in Zimmer Biomet Holdings Inc (ZMH) by 70,255 shares in the quarter, leaving it with 138,500 shares, and cut its stake in Stericycle Inc (NASDAQ:SRCL).

Investors sentiment increased to 1.48 in Q2 2017. Its up 0.04, from 0.64 in 2017Q1. Verity Asset Management Inc. raised its holdings in shares of CVS Health by 11.9% during the 2nd quarter.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. 803.96 million shares or 0.96% less from 811.73 million shares in 2017Q1 were reported. Sei Invs Company, Pennsylvania-based fund reported 1.89M shares. 390,923 are held by Jane Street Ltd Liability. 90,267 CVS Health Corporation (NYSE:CVS) shares with value of $7.19 million were sold by Moriarty Thomas M. The insider Denton David M sold $18.88 million. The stock of CVS Health Corporation (NYSE:CVS) earned "Buy" rating by Jefferies on Thursday, May 12. Grimes And reported 99,448 shares. Private Advisor Limited Liability Com accumulated 37,394 shares. First Business Svcs reported 6,495 shares. State Of Tennessee Treasury Department holds 353,653 shares. Bailard invested in 0.37% or 58,424 shares. Traynor Capital Management Inc. now owns 3,676 shares of the pharmacy operator's stock worth $290,000 after purchasing an additional 48 shares during the period. On Friday, September 15 the insider Foulkes Helena sold $3.22 million. CVS's profit will be $1.92 billion for 9.62 P/E if the $1.90 EPS becomes a reality. Loop Capital began coverage on CVS Health in a research report on Thursday, August 24th. Leerink Swann set a $90.00 price objective on shares of CVS Health Corporation and gave the stock a "buy" rating in a research note on Tuesday, June 27th. Therefore 68% are positive. Analysts predict that CVS Health Corporation will post $5.87 earnings per share for the current fiscal year. Finally, Raymond James Financial reaffirmed a "buy" rating on shares of CVS Health in a research note on Monday, December 4th. The firm has "Peer Perform" rating by Wolfe Research given on Monday, August 14. The rating was upgraded by Needham on Friday, November 10 to "Buy". Mizuho maintained the shares of CVS in report on Thursday, June 23 with "Buy" rating. As per Thursday, August 20, the company rating was maintained by Deutsche Bank. CVS Health Corporation now has an average rating of "Buy" and an average price target of $93.98.

Altre relazioniGrafFiotech

Discuti questo articolo

Segui i nostri GIORNALE